GlobeNewswire by notified

Scandinavian Tobacco Group A/S: Transactions in connection with share buy-back programme

Company Announcement
No. 3/2023

Copenhagen, 16 January 2023

Transactions in connection with share buy-back programme

On 19 May 2022, Scandinavian Tobacco Group A/S announced that the share buy-back programme that was initiated 9 March 2022 was increased to an aggregated value of up to DKK 1,000 million. The purpose of the programme is to adjust the Company’s capital structure and meet obligations relating to the Group’s share-based incentive programme.

Part of the buy-back programme is executed in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (the “Market Abuse Regulation”) and Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour rules. Another part of the share buy-back programme is conducted as a directed buy-back from Chr. Augustinus Fabrikker Aktieselskab and C.W. Obel A/S as further described in company announcement no. 35/2022. The share buy-back programme will end no later than 28 February 2023.

The following transactions have been executed from 9 January to 13 January 2023:

Number of sharesAverage
purchase price, DKK
Transaction value, DKK
Accumulated, last announcement 5,358,524685,994,773
9-Jan-23  15,000 115.58  1,733,666
10-Jan-23  7,933 114.33  906,949
11-Jan-23  11,650 113.88  1,326,650
12-Jan-23  10,866 112.88  1,226,587
13-Jan-23  11,712 113.36  1,327,648
Total, 9 January – 13 January 2023 57,161  114.09  6,521,498
Bought from CAF, 13 January 2023*  25,510  114.09  2,910,436
Bought from CWO, 13 January 2023*  11,809  114.09  1,347,289
Accumulated under the programme5,453,004696,773,996

*According to separate agreements as from 20 May 2022 Chr. Augustinus Fabrikker Aktieselskab (CAF) participates on a 27.0% pro-rata basis and C.W.Obel A/S (CWO) participates on a 12.5% pro-rata basis to the shares purchased in the share buy-back programme.

A detailed overview of transactions during the period 9 January – 13 January 2023 is attached to this announcement.

Following the above transactions Scandinavian Tobacco Group A/S owns a total of 5,899,066 treasury shares, corresponding to 6.34% of the total share capital.

For further information, please contact:
Torben Sand, Head of Investor Relations,
phone: +45 5084 7222 or

About Scandinavian Tobacco Group

Scandinavian Tobacco Group A/S is a world-leading manufacturer of handmade and machine-rolled cigars with an annual production of more than four billion cigars. The Group holds market-leading positions in several categories and its products are sold in more than 100 markets.

Scandinavian Tobacco Group has its headquarters in Copenhagen, Denmark – and employs approximately 10,000 people in Europe, the US, Canada, the Dominican Republic, Honduras, Nicaragua, Indonesia and Sri Lanka. For more information please visit


To view this piece of content from, please give your consent at the top of this page.
To view this piece of content from, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Ilkka Oyj – Acquisition of own shares on 27 March 202327.3.2023 18:00:00 CEST | Press release

ILKKA OYJ, STOCK EXCHANGE RELEASE, 27 March 2023 at 19:00 EET IlkkaOyj – Acquisition of own shares on 27 March 2023 At Nasdaq Helsinki Ltd: Date27 March 2023Exchange transactionBuyShare trading codeILKKA2Amount, shares 453Average price/share, EUR3.8044Total cost, EUR1,723.39 The company holds a total of 82,890 of its own shares (ILKKA2) including the shares acquired on 27 March 2023. Detailed information concerning the acquisition is attached to this stock exchange release. On behalf of Ilkka Oyj DANSKE BANK A/S, FINLAND BRANCH Jonathan Nyberg Antti Väliaho Additional information Olli Pirhonen, CEO, Ilkka Oyj, tel. +358 40 766 5418 Attachment Ilkka buyback 27.3.2023

Mendus announces request for conversion of convertible bonds by Negma Group27.3.2023 18:00:00 CEST | Press release

Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced that Negma Group (“Negma”) has by notice to Mendus requested the conversion of convertible bonds that have been issued to Negma in accordance with the financing agreement announced by Mendus through press releases on 26 August and 26 October 2022. Negma has requested conversion of six (6) convertible bonds issued on 3 January 2023, corresponding to SEK 150,000 of the convertible loan amounting to a total of SEK 5,425,000, into 127,118 shares. Upon registration at the Swedish Companies Registration Office, Mendus’ total share capital will amount to SEK 10,071,926.2 and the total number of shares and votes will amount to 201,438,524. The conversion price per share is SEK 1.18, equivalent to 92% of the second lowest closing volume weighted average share price (VWAP) of the 10 consecutive trading days preceding the issuance of conversion request by Negma.

Mendus tillkännager begäran från Negma Group om konvertering av konvertibla skuldebrev27.3.2023 18:00:00 CEST | Pressemelding

Mendus AB (“Mendus” publ; IMMU.ST), ett bioläkemedelsföretag fokuserat på immunterapier mot tumöråterfall, tillkännager idag att Negma Group (”Negma”) genom meddelande till Mendus har begärt konvertering av konvertibla skuldebrev som utfärdats till Negma i enlighet med det finansieringsavtal som Mendus tillkännagivit genom pressmeddelanden den 26 augusti och 26 oktober 2022. Negma har begärt konvertering av sex (6) konvertibla skuldebrev som emitterades den 3 januari 2023, motsvarande 150 000 kronor av det konvertibla lånet som uppgår till totalt 5 425 000 kronor, till 127 118 aktier. Efter registrering hos Bolagsverket kommer Mendus totala aktiekapital att uppgå till 10 071 926,2 kronor och det totala antalet aktier och röster kommer att uppgå till 201 438 524. Konverteringspriset per aktie är 1,18 kronor, motsvarande 92% av den näst lägsta dagliga volymvägda genomsnittliga aktiekursen (VWAP) under de 10 på varandra följande handelsdagarna före konverteringsbegäran från Negma. För ytt

Aspo Plc: Share Repurchase 27.3.202327.3.2023 17:30:00 CEST | Press release

Aspo PlcAnnouncement 27.3.2023Aspo Plc: Share Repurchase 27.3.2023In the Helsinki Stock ExchangeTrade date27.3.2023Bourse tradeBuyShareASPOAmount2,400SharesAverage price/ share8.4629EURTotal cost20,310.96EURAspo Plc now holds a total of 90 932 sharesincluding the shares repurchased on 27.3.2023On behalf of Aspo PlcNordea Bank OyjJanne SarvikiviSami HuttunenFurther information, please contact:Arto Meitsalo, CFO, Aspo Plc, tel. +358 40 5511 422, Attachment ASPO_27.3_trades

NGS Group AB: Offentliggör årsredovisning 202227.3.2023 17:30:00 CEST | Pressemelding

Härmed offentliggör NGS Group AB (publ) sin årsredovisning för 2022. Årsredovisningen finns även tillgänglig på bolagets hemsida För att erhålla ett tryckt exemplar av årsredovisningen, vänligen kontakta bolaget via e-post på För ytterligare information kontakta: Thomas Plate, tf CFO för NGS Group på telefon 076-894 9239 eller mailadress Denna information är sådan som NGS Group AB (publ) är skyldig att offentliggöra enligt lagen om värdepappersmarknaden, lagen om handel med finansiella instrument samt Nasdaq Stockholms regelverk. Informationen lämnades för offentliggörande den 27 mars 2023 kl. 17:30. Bilagor ngsgroupab-2022-12-31-svÅR NGS Group 2022